Ohr Pharmaceutical to Present at 2016 Ophthalmology Innovation Summit on October 13
Oct 11, 2016 12:02 pm UTC| Business
NEW YORK, Oct. 11, 2016 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that the company has been selected to present at the 2016 Ophthalmology Innovation...
Oct 11, 2016 12:02 pm UTC| Business
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies,...
Oct 11, 2016 12:02 pm UTC| Business
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies,...
Oct 11, 2016 12:02 pm UTC| Business
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies,...
Oct 11, 2016 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Oct 11, 2016 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Oct 11, 2016 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...